Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board

    NEXT STORY
    Infusion Pumps & Accessories: Worldwide Market Outlook, 2026 – Market Expansion Opportunities in Emerging Nations
    PREV STORY
    Roche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets Authority
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Adaptimmune Announces Changes to Board of Directors

    author_avatar
    NASDAQ Market News

    G1 Therapeutics to Present Preliminary Data from Randomized Phase 2 Trial of Trilaciclib in Metastatic Triple-Negative Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS)

    RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: ...

    author_avatar
    NASDAQ Market News

    Maru/Matchbox Appoints Industry Veteran, Rich Durante as Managing Director, Pharmaceuticals and Medicines

    author_avatar
    NASDAQ Market News